In Vitro and in Vivo Antitrypanosomal Activitiy of Two Microbial Metabolites, KS-505a and Alazopeptin

被引:0
|
作者
Aki Ishiyama
Kazuhiko Otoguro
Miyuki Namatame
Aki Nishihara
Toshiaki Furusawa
Rokuro Masuma
Kazuro Shiomi
Yoko Takahashi
Michio Ichimura
Haruki Yamada
Satoshi Ōmura
机构
[1] Research Center for Tropical Diseases,
[2] Center for Basic Research,undefined
[3] Kitasato University,undefined
[4] Kitasato Institute for Life Sciences and Graduate School of Infectious Control Sciences,undefined
[5] Kitasato University,undefined
[6] BioFrontier Laboratories,undefined
[7] Kyowa Hakko Kogyo Co.,undefined
[8] Ltd.,undefined
来源
关键词
screening; antitrypanosomal antibiotics; HAT;
D O I
暂无
中图分类号
学科分类号
摘要
Our on-going screening program to discover new antitrypanosomal antibiotics has been evaluating compounds isolated from soil microorganisms as well as investigating the antibiotic libraries of the Kitasato Institute for Life Sciences and BioFrontier Laboratories of Kyowa Hakko Kogyo Co., Ltd. We have now discovered two compounds, KS-505a and alazopeptin, which exhibit moderate antitrypanosomal characteristics. We report here the in vitro and in vivo antitrypanosomal activities and cytotoxicities of KS-505a and alazopeptin, compared with some commonly-used antitrypanosomal drugs. This is the first report of in vitro and in vivo antitrypanosomal activities of either KS-505a or alazopeptin.
引用
收藏
页码:627 / 632
页数:5
相关论文
共 7 条
  • [1] In Vitro and in Vivo Antitrypanosomal Activitiy of Two Microbial Metabolites, KS-505a and Alazopeptin
    Ishiyama, Aki
    Otoguro, Kazuhiko
    Namatame, Miyuki
    Nishihara, Aki
    Furusawa, Toshiaki
    Masuma, Rokuro
    Shiomi, Kazuro
    Takahashi, Yoko
    Ichimura, Michio
    Yamada, Haruki
    Omura, Satoshi
    JOURNAL OF ANTIBIOTICS, 2008, 61 (10): : 627 - 632
  • [2] Selective and Potent in Vitro Antitrypanosomal Activities of Ten Microbial Metabolites
    Kazuhiko Otoguro
    Aki Ishiyama
    Miyuki Namatame
    Aki Nishihara
    Toshiaki Furusawa
    Rokuro Masuma
    Kazuro Shiomi
    Yoko Takahashi
    Haruki Yamada
    Satoshi Ōmura
    The Journal of Antibiotics, 2008, 61 : 372 - 378
  • [3] Selective and potent in vitro antitrypanosomal activities of ten microbial metabolites
    Otoguro, Kazuhiko
    Ishiyama, Aki
    Namatame, Miyuki
    Nishihara, Aki
    Furusawa, Toshiaki
    Masuma, Rokuro
    Shiomi, Kazuro
    Takahashi, Yoko
    Yamada, Haruki
    Omura, Satoshi
    JOURNAL OF ANTIBIOTICS, 2008, 61 (06): : 372 - 378
  • [4] Microbial Metabolites of Omeprazole Activate Murine Aryl Hydrocarbon Receptor In Vitro and In Vivo
    Shiizaki, Kazuhiro
    Kawanishi, Masanobu
    Yagi, Takashi
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (10) : 1690 - 1697
  • [5] Neuroprotective effects of urolithins, pomegranate ellagitannin-gut microbial derived metabolites: In silico, in vitro, and in vivo studies
    Niesen, Daniel
    Yuan, Tao
    Ma, Hang
    Shah, Nishan
    Liu, Weixi
    Crews, Rebecca
    Vattem, Dhiraj
    Seeram, Navindra
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [6] In vitro and in vivo metabolism of a gamma-secretase inhibitor BMS-299897 and generation of active metabolites in milligram quantities with a microbial bioreactor
    Zhang, Donglu
    Hanson, Ronald
    Roongta, Vikram
    Dischino, Douglas D.
    Gao, Qi
    Sloan, Charles P.
    Polson, Craig
    Keavy, Daniel
    Zheng, Ming
    Mitroka, James
    Yeola, Suresh
    CURRENT DRUG METABOLISM, 2006, 7 (08) : 883 - 896
  • [7] Pyrogallol, a microbial metabolites from mango tannins (Mangifera Indica L.) suppresses breast cancer ductal carcinoma in situ proliferation in both in vitro and in vivo
    Mertens-Talcott, Susanne U.
    Kim, Hyemee
    Barnes, Ryan
    Talcott, Stephen T.
    Nemec, Matthew
    FASEB JOURNAL, 2016, 30